K

Kendall South Medical Center, Inc | Miami, FL

Research site

(Unclaimed)

Location

14740 sw 26 street, suite 107, Miami, Florida, United States of America

Site insights

Top conditions

Top treatments

Ritonavir

RN316

PF-07321332

PF-04950615

Bococizumab

Linagliptin

Tanezumab

Tasimelteon

ABBV-105

Glimepiride

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

2 of 28 total trials

Phase 3 Study of S-217622 in Prevention of Symptomatic SARS-CoV-2 Infection (SCORPIO-PEP)

The purpose of this study is to measure the proportion of participants who are infected with severe acute respiratory syndrome coronavirus 2 (SARS-Co...

Enrolling

SARS-CoV-2 Infection

Drug: Placebo

Drug: S-217622

Randomized Study to Evaluate the Effect of Obicetrapib on Top of Maximum Tolerated Lipid-Modifying Therapies (BROADWAY)

This study will be a placebo-controlled, double-blind, randomized, phase 3 study in participants with underlying heterozygous familial hypercholester...

Active, not recruiting

Atherosclerotic Cardiovascular Disease

Dyslipidemias

Drug: Placebo

Drug: Obicetrapib